Casellas J M, Blanco M G, Pinto M E
Infectious Diseases and Clinical Microbiology Department, Postgraduate School of Health Sciences, Catholic University, Buenos Aires, Argentina.
Infect Dis Clin North Am. 1994 Mar;8(1):29-45.
Resistance to most of the antimicrobial agents in use today is present in Latin America as of this publication. Their underlying mechanisms are in place and an even more serious situation is foreseen in the years to come. Both nosocomial and common community-acquired infections have changed to require more complex ways of management. Although newer antibiotics take the place of the older ones, wiser and more restrictive usage of the currently available antibiotics is needed. This may be obtained through education and with the amplification of national and supranational networks of surveillance, which could anticipate trends in resistance.
截至本出版物发布时，拉丁美洲已出现对当今使用的大多数抗菌药物的耐药性。其潜在机制已经存在，预计未来几年情况将更加严峻。医院感染和常见的社区获得性感染都已发生变化，需要更复杂的管理方式。虽然新型抗生素取代了旧型抗生素，但需要更明智、更严格地使用现有抗生素。这可以通过教育以及扩大国家和超国家监测网络来实现，这些网络可以预测耐药性趋势。
